Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo
Roche obesity drug shows 22.5% weight loss in Phase-II trialRoche focuses on catching Lilly in $150 billion obesity…
Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports
BERLIN, March 3 (Reuters) – Swiss pharmaceutical company Roche (ROG.S), opens new tab is aiming for a double-digit…
Roche boosts US presence with new $700 million North Carolina facility
May 12 (Reuters) – Roche Group (ROG.S), opens new tab said on Monday that it plans to invest…
Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
Item 1 of 2 The logo of Swiss drugmaker Novartis is seen at the company’s new cell and…